
Demand for COVID vaccine drops, BioNTech revenue falls
BioNTech’s performance fell more than expected after four consecutive quarters of revenue of more than 5 billion euros ($5.1 billion) as demand for the new
BioNTech’s performance fell more than expected after four consecutive quarters of revenue of more than 5 billion euros ($5.1 billion) as demand for the new